Implementation and Effectiveness of an Interprofessional Support Program for Patients with Type 2 Diabetes in Swiss Primary Care: A Study Protocol.

community pharmacy implementation science interprofessional practice medication adherence patient support type 2 diabetes

Journal

Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532

Informations de publication

Date de publication:
21 Jun 2020
Historique:
received: 19 05 2020
revised: 17 06 2020
accepted: 19 06 2020
entrez: 25 6 2020
pubmed: 25 6 2020
medline: 25 6 2020
Statut: epublish

Résumé

This research protocol illustrates the use of implementation science to support the development, dissemination and integration in primary care of effective and sustainable collaborative pharmacy services for chronic care management. The objective is to evaluate the implementation and the effectiveness of a pharmacist-led patient support program including regular motivational interviews; medication adherence, patient-reported outcomes, and clinical outcomes monitoring; and interactions with physicians, for patients with type 2 diabetes taking at least one oral antidiabetic medication in the French-speaking part of Switzerland. This is a prospective, multi-centered, observational, cohort study using a hybrid design to assess the patient support program. The evaluation includes three levels of analysis: (1) the implementation strategies, (2) the overall implementation process, and (3) the effectiveness of the program. Qualitative and quantitative methods are used, and outcomes are assessed at each stage of the implementation process: exploration, preparation, operation, and sustainability. This research project will provide key insights into the processes of implementing patient support programs on a large scale and adapting the traditional community pharmacy practices towards the delivery of person-centered and collaborative services.

Identifiants

pubmed: 32575887
pii: pharmacy8020106
doi: 10.3390/pharmacy8020106
pmc: PMC7357028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Federal Office of Public Health
ID : 15.003846
Organisme : Swiss fund of quality and research RPB IV/1
ID : 20160201

Références

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S64-9
pubmed: 12324988
Risk Manag Healthc Policy. 2016 Jul 05;9:143-56
pubmed: 27462182
Health Policy. 2016 Dec;120(12):1350-1362
pubmed: 28228230
Br J Clin Pharmacol. 2012 May;73(5):691-705
pubmed: 22486599
Int J Clin Pharm. 2014 Feb;36(1):55-69
pubmed: 24166659
Clin Ther. 2011 Jan;33(1):74-109
pubmed: 21397776
Prev Med Rep. 2018 Oct 19;12:284-293
pubmed: 30406006
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
Int J Clin Pharm. 2016 Oct;38(5):1210-8
pubmed: 27473709
Pharm World Sci. 2010 Dec;32(6):776-86
pubmed: 20862544
Med J Aust. 2004 Mar 15;180(S6):S50-1
pubmed: 15012580
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Qual Health Res. 2016 Nov;26(13):1753-1760
pubmed: 26613970
BMC Health Serv Res. 2019 Jan 8;19(1):15
pubmed: 30621697
Int J Clin Pharm. 2014 Oct;36(5):1014-22
pubmed: 25139136
Front Pharmacol. 2019 Jan 29;9:1567
pubmed: 30761009
BMC Health Serv Res. 2018 Nov 20;18(1):874
pubmed: 30458844
Am J Manag Care. 2015 Jan 01;21(1):e23-34
pubmed: 25880265
Res Social Adm Pharm. 2016 May-Jun;12(3):515-22
pubmed: 26341944
Health Res Policy Syst. 2015 Mar 14;13:16
pubmed: 25885055
Soc Sci Med. 2010 Nov;71(10):1811-8
pubmed: 20933316
Biomed Res Int. 2015;2015:103546
pubmed: 26839879
Am J Health Syst Pharm. 2019 Jul 18;76(15):1150-1157
pubmed: 31201774
BMC Health Serv Res. 2018 Sep 10;18(1):698
pubmed: 30200960
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Adm Policy Ment Health. 2011 Jan;38(1):4-23
pubmed: 21197565
BMC Health Serv Res. 2016 Aug 25;16:439
pubmed: 27562631
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Ageing Res Rev. 2011 Sep;10(4):430-9
pubmed: 21402176
Res Social Adm Pharm. 2017 Sep - Oct;13(5):1014-1027
pubmed: 28434918
Implement Sci. 2012 Apr 24;7:38
pubmed: 22531013
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Implement Sci. 2018 Jul 31;13(1):105
pubmed: 30064454
Health Psychol. 2006 Jul;25(4):462-73
pubmed: 16846321
BMC Health Serv Res. 2020 May 14;20(1):425
pubmed: 32410681
Qual Life Res. 1999;8(1-2):79-91
pubmed: 10457741

Auteurs

Noura Bawab (N)

Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Lausanne, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.

Joanna C Moullin (JC)

Faculty of Health Sciences, Curtin University, Bentley WA 6102, Australia.

Clémence Perraudin (C)

Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland.

Olivier Bugnon (O)

Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Lausanne, Rue Michel-Servet 1, 1211 Geneva 4, Switzerland.

Classifications MeSH